Wang, Yongxiang
Han, Qi
Han, Xiaolei
Dong, Yi
Mao, Ming
Wang, Chaoqun
Wang, Xiaojie
Tang, Shi
Liu, Cuicui
Li, Yuanjing
Hou, Tingting
Cong, Lin
Du, Yifeng
Qiu, Chengxuan
Funding for this research was provided by:
Alzheimer’s Association Grant (AACSFD-22-922844)
National Natural Science Foundation of China (82171175)
Natural Science Foundation of Shandong Province (ZR2021MH005)
Academic Promotion Program of Shandong First Medical University (2019QL020)
Swedish Research Council (2017-05819)
Swedish Foundation for International Cooperation in Research and Higher Education (CH2019-8320)
Karolinska Institute
Article History
Received: 14 September 2022
Accepted: 13 July 2023
First Online: 25 July 2023
Declarations
:
: The Ethics Committee at Shandong Provincial Hospital approved the protocol of MIND-China. Written informed consent was obtained from all the participants. MIND-China was registered in the Chinese Clinical Trial Registry (registration no.: ChiCTR1800017758).
: Not applicable.
: The authors declare that they have no competing interests.